Aligos Therapeutics $150 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Array Technologies $1.2 billion IPO
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion initial public offering of 54,625,000 shares of common…
Aziyo Biologics $50 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public offering of common stock by Aziyo Biologics, Inc. The common stock…
Gilead Sciences $7.25 billion senior notes offering
Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal amount of senior notes, consisting of (i) $500 million aggregate…
Jamf Holding $538.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $538.2 million initial public offering of 20,700,000 shares of common stock of Jamf Holding Corp.,…